author-photo

P. García Alfonso

Hospital General Universitario Gregorio Marañón

16

Papers

92

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept.

2021 Clinical & Translational Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.

2020 Clinical & Translational Oncology
Show All
- Source
- Cite
- Save
Citations (3)
O-026Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC)

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (12)
PD-011Mutational profile of non-metastatic anal squamous cell carcinoma: a restrictive high impact genetic variants analysis

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P-190Update of metastatic colorectal cancer metastases resection after FOLFIRI-aflibercept in oxaliplatin-refractory patients

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
P-163Whole-exome sequencing of non-metastatic anal squamous cell carcinoma: a prognostic genetic variants analysis

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

2019 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (7)
LBA-006BEACON CRC: a randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E–mutant metastatic colorectal cancer

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (16)
602PSafety and effectiveness of aflibercept + FOLFIRI for the treatment of patients with metastatic colorectal cancer (mCRC): OZONE secondary analyses

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
531PDSequential RAS mutation testing in cfDNA in RAS wild type (wt) metastatic colorectal cancer (mCRC) patients (pt) treated with panitumumab (P) and chemotherapy (CT) in first-line (1L): PERSEIDA study

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)